Chemed (CHE) to Release Quarterly Earnings on Wednesday

Chemed (NYSE:CHE) is anticipated to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Chemed to post earnings of $6.78 per share and revenue of $636.10 million for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Chemed Price Performance

Shares of NYSE:CHE opened at $544.75 on Monday. The business’s 50-day moving average is $542.60 and its 200 day moving average is $563.67. The firm has a market capitalization of $8.20 billion, a P/E ratio of 27.53, a P/E/G ratio of 2.15 and a beta of 0.48. Chemed has a 1 year low of $512.12 and a 1 year high of $654.62.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Monday, February 24th will be paid a $0.50 dividend. The ex-dividend date is Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.37%. Chemed’s payout ratio is 10.11%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on CHE shares. Royal Bank of Canada reduced their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th.

Insider Buying and Selling at Chemed

In other Chemed news, EVP Spencer S. Lee sold 732 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $575.62, for a total value of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. This represents a 3.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Brian C. Judkins purchased 145 shares of the stock in a transaction dated Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the acquisition, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. The trade was a 9.46 % increase in their position. The disclosure for this purchase can be found here. 3.32% of the stock is owned by corporate insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.